The Indian pharmaceutical giant, Zydus Cadila, is facing financial distress and this presents an unmissable opportunity for major players in the global pharmaceutical market. A recent slump in share prices has signaled potential vulnerability, making it a prime target for companies looking to increase their reach. With a rich history and expertise